Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome
- 13 May 2005
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 20 (7), 914-919
- https://doi.org/10.1007/s00467-005-1877-x
Abstract
Attempts to minimize the effects of prolonged steroid use in steroid-dependent nephrotic syndrome (SDNS) and the need to overcome steroid resistance (SRNS) justifies immunosuppressant therapy. We report our experience in a cohort of patients with SD/SRNS during the administration of mycophenolate mofetil (MMF) in a prospective protocol initiated in January 2001. Twenty-six children with idiopathic nephrotic syndrome were included (21 steroid dependent and 5 steroid resistant), whose response did not change after sequential treatment with cyclophosphamide (CPM) and cyclosporine (CsA). Histopathologic patterns were: 11 minimal change disease (MCD), 1 diffuse mesangial proliferation (DMP), 13 focal segmental glomerulosclerosis (FSGS) and membranous 1 glomerulonephritis (MGN). The median age of onset of NS was 2.8 years (range 1.2–12.5), and treatment with MMF was performed at a median age of 11.4 years (range 5–17) with an initial dose of 600 mg/m2/12 h, adjusted to maintain levels of mycophenolic acid (MPA) at 2.5–5 mcg/ml. The planned duration of study to assess treatment efficacy was 6 months. The mean MMF dose required was 624 (SD=136) mg/m2/12 h (range 415–970), which maintained mean C0-MPA levels of 2.9 (SD=1.17) mcg/ml (range 1.2–5.9 mcg/ml). In the five patients with SRNS, only one achieved complete remission. In the patients with SDNS, steroid sparing was achieved in 15 and 9 remained in remission on MMF monotherapy. Withdrawal of MMF resulted in immediate relapse in 47%. In our study, MMF was a useful immunosuppressant due to its fewer undesirable effects and similar efficacy to other drugs used. It appears effective for the maintenance of remission in SDNS patients, with a response similar to that of CsA.Keywords
This publication has 30 references indexed in Scilit:
- Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndromePediatric Nephrology, 2003
- Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndromeNephrology, 2003
- Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndromeNephrology Dialysis Transplantation, 2002
- Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndromeKidney International, 2002
- Mycophenolate mofetil treatment for primary glomerular diseasesKidney International, 2002
- Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trialsKidney International, 2001
- A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndromeKidney International, 2000
- One-center experience with cyclosporine in refractory nephrotic syndrome in childrenPediatric Nephrology, 1999
- Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable diseasePediatric Nephrology, 1996
- Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agentsPediatric Nephrology, 1990